143 related articles for article (PubMed ID: 36515849)
1. Quantification of PARP7 Protein Levels and PARP7 Inhibitor Target Engagement in Cells Using a Split Nanoluciferase System.
Duell AK; Sanderson DJ; Cohen MS
Methods Mol Biol; 2023; 2609():387-395. PubMed ID: 36515849
[TBL] [Abstract][Full Text] [Related]
2. PARP7 and Mono-ADP-Ribosylation Negatively Regulate Estrogen Receptor α Signaling in Human Breast Cancer Cells.
Rasmussen M; Tan S; Somisetty VS; Hutin D; Olafsen NE; Moen A; Anonsen JH; Grant DM; Matthews J
Cells; 2021 Mar; 10(3):. PubMed ID: 33799807
[TBL] [Abstract][Full Text] [Related]
3. PARP7 mono-ADP-ribosylates the agonist conformation of the androgen receptor in the nucleus.
Kamata T; Yang CS; Paschal BM
Biochem J; 2021 Aug; 478(15):2999-3014. PubMed ID: 34264286
[TBL] [Abstract][Full Text] [Related]
4. PARP7-mediated ADP-ribosylation of FRA1 promotes cancer cell growth by repressing IRF1- and IRF3-dependent apoptosis.
Manetsch P; Böhi F; Nowak K; Leslie Pedrioli DM; Hottiger MO
Proc Natl Acad Sci U S A; 2023 Dec; 120(49):e2309047120. PubMed ID: 38011562
[TBL] [Abstract][Full Text] [Related]
5. Methods to Study TCDD-Inducible Poly-ADP-Ribose Polymerase (TIPARP) Mono-ADP-Ribosyltransferase Activity.
Hutin D; Grimaldi G; Matthews J
Methods Mol Biol; 2018; 1813():109-124. PubMed ID: 30097864
[TBL] [Abstract][Full Text] [Related]
6. TCDD-inducible poly-ADP-ribose polymerase (TIPARP/PARP7) mono-ADP-ribosylates and co-activates liver X receptors.
Bindesbøll C; Tan S; Bott D; Cho T; Tamblyn L; MacPherson L; Grønning-Wang L; Nebb HI; Matthews J
Biochem J; 2016 Apr; 473(7):899-910. PubMed ID: 26814197
[TBL] [Abstract][Full Text] [Related]
7. Characterization of TCDD-inducible poly-ADP-ribose polymerase (TIPARP/ARTD14) catalytic activity.
Gomez A; Bindesbøll C; Satheesh SV; Grimaldi G; Hutin D; MacPherson L; Ahmed S; Tamblyn L; Cho T; Nebb HI; Moen A; Anonsen JH; Grant DM; Matthews J
Biochem J; 2018 Dec; 475(23):3827-3846. PubMed ID: 30373764
[TBL] [Abstract][Full Text] [Related]
8. Reduced Colonic Mucosal Injury in 2,3,7,8-Tetrachlorodibenzo-
Hutin D; Hagen KA; Shao P; Sugamori K; Grant DM; Matthews J
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055106
[TBL] [Abstract][Full Text] [Related]
9. Enabling drug discovery for the PARP protein family through the detection of mono-ADP-ribosylation.
Lu AZ; Abo R; Ren Y; Gui B; Mo JR; Blackwell D; Wigle T; Keilhack H; Niepel M
Biochem Pharmacol; 2019 Sep; 167():97-106. PubMed ID: 31075269
[TBL] [Abstract][Full Text] [Related]
10. In Vitro and Cellular Probes to Study PARP Enzyme Target Engagement.
Wigle TJ; Blackwell DJ; Schenkel LB; Ren Y; Church WD; Desai HJ; Swinger KK; Santospago AG; Majer CR; Lu AZ; Niepel M; Perl NR; Vasbinder MM; Keilhack H; Kuntz KW
Cell Chem Biol; 2020 Jul; 27(7):877-887.e14. PubMed ID: 32679093
[TBL] [Abstract][Full Text] [Related]
11. Androgen signaling uses a writer and a reader of ADP-ribosylation to regulate protein complex assembly.
Yang CS; Jividen K; Kamata T; Dworak N; Oostdyk L; Remlein B; Pourfarjam Y; Kim IK; Du KP; Abbas T; Sherman NE; Wotton D; Paschal BM
Nat Commun; 2021 May; 12(1):2705. PubMed ID: 33976187
[TBL] [Abstract][Full Text] [Related]
12. Post-Transcriptional Regulation of PARP7 Protein Stability Is Controlled by Androgen Signaling.
Kamata T; Yang CS; Melhuish TA; Frierson HF; Wotton D; Paschal BM
Cells; 2021 Feb; 10(2):. PubMed ID: 33572475
[TBL] [Abstract][Full Text] [Related]
13. 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD)-Inducible Poly-ADP-Ribose Polymerase (TIPARP/PARP7) Catalytic Mutant Mice (TiparpH532A) Exhibit Increased Sensitivity to TCDD-Induced Hepatotoxicity and Lethality.
Hutin D; Long AS; Sugamori K; Shao P; Singh SK; Rasmussen M; Olafsen NE; Pettersen S; Grimaldi G; Grant DM; Matthews J
Toxicol Sci; 2021 Aug; 183(1):154-169. PubMed ID: 34129049
[TBL] [Abstract][Full Text] [Related]
14. Structurally distinct PARP7 inhibitors provide new insights into the function of PARP7 in regulating nucleic acid-sensing and IFN-β signaling.
Sanderson DJ; Rodriguez KM; Bejan DS; Olafsen NE; Bohn ID; Kojic A; Sundalam S; Siordia IR; Duell AK; Deng N; Schultz C; Grant DM; Matthews J; Cohen MS
Cell Chem Biol; 2023 Jan; 30(1):43-54.e8. PubMed ID: 36529140
[TBL] [Abstract][Full Text] [Related]
15. Uncovering the Invisible: Mono-ADP-ribosylation Moved into the Spotlight.
Hopp AK; Hottiger MO
Cells; 2021 Mar; 10(3):. PubMed ID: 33808662
[TBL] [Abstract][Full Text] [Related]
16. Discovery of the Potent and Highly Selective PARP7 Inhibitor as a Novel Immunotherapeutic Agent for Tumors.
Gu H; Yan W; Wang Y; Xu W; Huang L; Yang J; Zhai B; Wang H; Su Y; Zhu Q; Liu B; Hao H; Zou Y; Xu Y
J Med Chem; 2023 Jan; 66(1):473-490. PubMed ID: 36576395
[TBL] [Abstract][Full Text] [Related]
17. Chemical genetic methodologies for identifying protein substrates of PARPs.
Rodriguez KM; Cohen MS
Trends Biochem Sci; 2022 May; 47(5):390-402. PubMed ID: 34366182
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms governing PARP expression, localization, and activity in cells.
Sanderson DJ; Cohen MS
Crit Rev Biochem Mol Biol; 2020 Dec; 55(6):541-554. PubMed ID: 32962438
[TBL] [Abstract][Full Text] [Related]
19. Forced Self-Modification Assays as a Strategy to Screen MonoPARP Enzymes.
Wigle TJ; Church WD; Majer CR; Swinger KK; Aybar D; Schenkel LB; Vasbinder MM; Brendes A; Beck C; Prahm M; Wegener D; Chang P; Kuntz KW
SLAS Discov; 2020 Mar; 25(3):241-252. PubMed ID: 31855104
[TBL] [Abstract][Full Text] [Related]
20. Roles of the ubiquitin ligase CUL4B and ADP-ribosyltransferase TiPARP in TCDD-induced nuclear export and proteasomal degradation of the transcription factor AHR.
Rijo MP; Diani-Moore S; Yang C; Zhou P; Rifkind AB
J Biol Chem; 2021 Aug; 297(2):100886. PubMed ID: 34146543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
